Lin Bioscience Inc
TPEX:6696
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lin Bioscience Inc
TPEX:6696
|
TW |
|
PostNL NV
OTC:TNTFF
|
NL |
|
AERWINS Technologies Inc
OTC:AWIN
|
JP |
|
S
|
Silverstock Metals Inc
CNSX:STK
|
CA |
|
S
|
Signify NV
OTC:PHPPY
|
NL |
|
M
|
Mitsubishi Chemical Group Corp
XMUN:M3C
|
JP |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FMEA
|
DE |
|
Nippon Kinzoku Co Ltd
TSE:5491
|
JP |
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
IN |
|
P
|
Perfectech International Holdings Ltd
HKEX:765
|
HK |
|
D
|
DCC PLC
SWB:DCC
|
IE |
|
M
|
Marcus Corp
F:3L1
|
US |
|
T
|
Tekcore Co Ltd
TPEX:3339
|
TW |
|
O
|
Orma Orman Mahsulleri Integre Sanayi ve Ticaret AS
IST:ORMA.E
|
TR |
|
E
|
Enerflex Ltd
NYSE:EFXT
|
CA |
Bankruptcy Probability
Lin Bioscience Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lin Bioscience Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
L
|
Lin Bioscience Inc
TPEX:6696
|
142.6B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
252.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
211.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
95.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lin Bioscience Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lin Bioscience Inc has total debt of 8.4m TWD. This includes both short-term (0 TWD) and long-term (8.4m TWD) debt.
You can find a full breakdown on its Balance Sheet.